9,10-dimethyl-1,2-benzanthracene has been researched along with B16 Melanoma in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (10.53) | 18.7374 |
| 1990's | 5 (26.32) | 18.2507 |
| 2000's | 7 (36.84) | 29.6817 |
| 2010's | 4 (21.05) | 24.3611 |
| 2020's | 1 (5.26) | 2.80 |
| Authors | Studies |
|---|---|
| Athar, M; Elmets, CA; Nasti, TH; Sherwani, MA; Timares, L; Yusuf, N | 1 |
| Callejas-Valera, JL; Cimas, FJ; Fernandez-Aroca, DM; Garcia-Gil, E; García-Olmo, DC; Gutkind, JS; Hernández-Losa, J; Marcos, P; Melgar-Rojas, P; Ortega-Muelas, M; Pascual-Serra, R; Ramón Y Cajal, S; Roche, O; Ruiz-Hidalgo, MJ; Sanchez-Prieto, R | 1 |
| Bald, T; Gaffal, E; Glodde, N; Hölzel, M; Jansen, P; Jönsson, G; Kalinke, U; Landsberg, J; Limmer, A; Lopez-Ramos, D; Renn, M; Steitz, J; Tolba, R; Tüting, T | 1 |
| Kuehl, PJ; Myrdal, PB; Powell, MB; Stratton, SP | 1 |
| Agrawal, RC; Pandey, S | 1 |
| Agrawal, RC; Beohar, T | 1 |
| Holmen, SL; McKinney, AJ | 1 |
| Banus, HA; de Gruijl, FR; Jongsma, MJ; Mullenders, LH; van Kranen, HJ; van Schanke, A; van Venrooij, GM | 1 |
| Cotter, MA; Florell, SR; Grossman, D; Hanks, AN; Liu, T; Robinette, K; Thomas, J | 1 |
| Balmain, A; Gause, PR; Keith, WN; Linardopolous, S; Lluria-Prevatt, M; Powell, MB; Warneke, J | 1 |
| Beyer, C; Blessing, M; Breuhahn, K; Mann, A; Ozbek, S; Rose-John, S; Rosenau, A; Schirmacher, P; Wilhelmi, A | 1 |
| Elenitsas, R; Kligman, LH | 1 |
| Berns, A; Krimpenfort, P; Loonstra, A; Mooi, WJ; Quon, KC | 1 |
| Huang, DS; Odeleye, OE; Watson, RR | 1 |
| Ingram, AJ | 1 |
| Baron, J; Folberg, R; Massicotte, SJ; Meyer, ML; Parys-Van Ginderdeuren, R; Pe'er, J; Worsey, H; Zimmerman, B | 1 |
| Donawho, C; Kripke, ML | 1 |
| Bucana, C; Kripke, ML; Romerdahl, CA; Stephens, LC | 1 |
| Gómez, S; Vicente, V | 1 |
2 review(s) available for 9,10-dimethyl-1,2-benzanthracene and B16 Melanoma
| Article | Year |
|---|---|
Animal models of melanoma: a somatic cell gene delivery mouse model allows rapid evaluation of genes implicated in human melanoma.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Avian Leukosis Virus; Avian Proteins; Cell Line, Tumor; Disease Models, Animal; Gene Transfer Techniques; Genetic Vectors; Humans; Melanocytes; Melanoma; Melanoma, Experimental; Mice; Mice, Transgenic; Neoplasm Transplantation; Receptors, Virus; Skin Neoplasms; Tetradecanoylphorbol Acetate; Transgenes | 2011 |
Review of chemical and UV light-induced melanomas in experimental animals in relation to human melanoma incidence.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Humans; Incidence; Melanoma; Melanoma, Experimental; Neoplasms, Radiation-Induced; Occupational Exposure; Polycyclic Compounds; Ultraviolet Rays | 1992 |
17 other study(ies) available for 9,10-dimethyl-1,2-benzanthracene and B16 Melanoma
| Article | Year |
|---|---|
Regulatory T Cells Play an Important Role in the Prevention of Murine Melanocytic Nevi and Melanomas.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; CD4 Antigens; CD8 Antigens; Female; Humans; Immune Tolerance; Male; Melanoma, Experimental; Mice; Mice, Knockout; Nevus, Pigmented; Skin; Skin Neoplasms; T-Lymphocytes, Regulatory; Tetradecanoylphorbol Acetate | 2021 |
E1a is an exogenous in vivo tumour suppressor.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Adenovirus E1A Proteins; Animals; Cell Proliferation; Cell Transformation, Neoplastic; Female; HCT116 Cells; Humans; Melanoma, Experimental; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Nude; Mice, Transgenic; Signal Transduction; Skin Neoplasms; Tetradecanoylphorbol Acetate; Time Factors; Transfection; Tumor Burden; Tumor Suppressor Proteins | 2017 |
Immune cell-poor melanomas benefit from PD-1 blockade after targeted type I IFN activation.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; B7-H1 Antigen; Carcinogens; Immunoglobulin G; Immunologic Factors; Interferon Type I; Melanoma, Experimental; Mice, Inbred C57BL; Mice, Transgenic; Poly I-C; Programmed Cell Death 1 Receptor; RNA; Tumor Microenvironment | 2014 |
Preformulation, formulation, and in vivo efficacy of topically applied apomine.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Administration, Topical; Animals; Anticarcinogenic Agents; Buffers; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Diphosphonates; Drug Stability; Ethanol; Hydrogen-Ion Concentration; Kinetics; Melanoma, Experimental; Mice; Ointments; Osmolar Concentration; ras Proteins; Skin Neoplasms; Solubility; Solvents; Technology, Pharmaceutical; Temperature | 2009 |
Evaluation of anticarcinogenic and antimutagenic potential of Bauhinia variegata extract in Swiss albino mice.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antimutagenic Agents; Antineoplastic Agents; Bauhinia; Carcinogens; Chromosome Aberrations; Croton Oil; Cyclophosphamide; Female; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Micronuclei, Chromosome-Defective; Papilloma; Phytotherapy; Plant Extracts; Skin Neoplasms; Xenograft Model Antitumor Assays | 2009 |
Chemopreventive and anticarcinogenic effects of Momordica charantia extract.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Bone Marrow Cells; Carcinogens; Chromosome Aberrations; Croton Oil; Female; Fruit; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Momordica charantia; Papilloma; Phytotherapy; Plant Extracts; Plant Leaves; Skin Neoplasms; Survival Rate | 2010 |
Induction of nevi and skin tumors in Ink4a/Arf Xpa knockout mice by neonatal, intermittent, or chronic UVB exposures.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Carcinoma, Squamous Cell; Cocarcinogenesis; Cyclin-Dependent Kinase Inhibitor p16; Melanoma, Experimental; Mice; Mice, Knockout; Neoplasms, Radiation-Induced; Nevus; Sarcoma; Skin Neoplasms; Tumor Suppressor Protein p14ARF; Ultraviolet Rays; Xeroderma Pigmentosum Group A Protein | 2006 |
Melanocyte expression of survivin promotes development and metastasis of UV-induced melanoma in HGF-transgenic mice.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Apoptosis; Cell Growth Processes; Female; Hepatocyte Growth Factor; Inhibitor of Apoptosis Proteins; Melanocytes; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Transgenic; Microtubule-Associated Proteins; Nevus, Pigmented; Repressor Proteins; Skin Pigmentation; Survivin; Tetradecanoylphorbol Acetate; Ultraviolet Rays | 2007 |
Chromosomal and genetic alterations of 7,12-dimethylbenz[a]anthracene-induced melanoma from TP-ras transgenic mice.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Blotting, Southern; Blotting, Western; Carcinogens; Carrier Proteins; Chromosome Aberrations; Chromosomes; Cyclin-Dependent Kinase Inhibitor p16; Genes, ras; In Situ Hybridization, Fluorescence; Melanoma, Experimental; Mice; Mice, Inbred C3H; Mice, Transgenic | 1997 |
Up- and down-regulation of granulocyte/macrophage-colony stimulating factor activity in murine skin increase susceptibility to skin carcinogenesis by independent mechanisms.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Carcinogens; Down-Regulation; Granulocyte-Macrophage Colony-Stimulating Factor; Keratin-10; Keratins; Melanoma, Experimental; Mice; Mice, Transgenic; Neoplasm Transplantation; Phenotype; Skin; Skin Neoplasms; Skin Physiological Phenomena; Tetradecanoylphorbol Acetate; Transgenes; Up-Regulation | 2001 |
Melanoma induction in a hairless mouse with short-term application of dimethylbenz[a]anthracene.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Carcinogens; Female; Lung Neoplasms; Lymphatic Metastasis; Melanoma, Experimental; Mice; Mice, Hairless; Skin Neoplasms; Time Factors | 2001 |
Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Carcinogens; Cell Transformation, Neoplastic; Cells, Cultured; Cyclin-Dependent Kinase Inhibitor p16; Embryo, Mammalian; Female; Fibroblasts; Gene Deletion; Genes, p16; Genes, ras; Genetic Predisposition to Disease; Humans; Male; Melanoma, Experimental; Mice; Point Mutation; Proteins; Tumor Suppressor Protein p14ARF | 2001 |
Inhibitory effects of canthaxanthin on in vitro growth of murine tumor cells.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Analysis of Variance; Animals; Canthaxanthin; Cell Division; Cell Line, Transformed; Cells, Cultured; Fibrosarcoma; Melanoma, Experimental; Mice; Sarcoma, Experimental; Tumor Cells, Cultured | 1992 |
Clinicopathologic spectrum of primary uveal melanocytic lesions in an animal model.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Choroid Neoplasms; Croton Oil; Disease Models, Animal; Fundus Oculi; Melanoma, Experimental; Rabbits | 1992 |
Immunogenicity and cross-reactivity of syngeneic murine melanomas.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Carcinoma, Squamous Cell; Cross Reactions; Croton Oil; Female; Fibrosarcoma; Melanoma, Experimental; Mice; Neoplasm Transplantation; Neoplasms, Radiation-Induced; Skin Neoplasms; Specific Pathogen-Free Organisms | 1990 |
The role of ultraviolet radiation in the induction of melanocytic skin tumors in inbred mice.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Croton Oil; Female; Male; Melanocytes; Melanoma, Experimental; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Neoplasms, Radiation-Induced; Sex Factors; Skin Neoplasms; Ultraviolet Rays | 1989 |
Protein S-100 immunostaining as a diagnostic tool for DMBA-induced melanotic lesions.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Guinea Pigs; Immunohistochemistry; Male; Melanoma, Experimental; Paraffin Embedding; S100 Proteins; Tissue Fixation | 1989 |